NCT05220969

Brief Summary

A total genotype risk score was generated based on the findings of previous research for non-contact injury, non-contact muscle injury, tendon injury, ligament injury, fracture injury and apophysitis injury. This score was then compared with the incidence of injury between those with high, medium and low risk scores for each injury. The influence of different rates of growth, stages of physical maturation and loading exposure were then also included in the risk model to see if any interaction effects could be observed between genetic risk score and susceptibility to injury in different categories of growth, maturation and loading exposure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 21, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
Last Updated

February 2, 2022

Status Verified

January 1, 2022

Enrollment Period

1.7 years

First QC Date

January 21, 2022

Last Update Submit

January 21, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Fracture Injury Risk

    Did the risk of fracture differ between total genotype risk score categories? was this affected by maturation?

    8 Years

  • Non-Contact Injury Risk

    Did the risk of non-contact injury differ between total genotype risk score categories? was this affected by maturation, and loading?

    8 Years

  • Non-Contact Muscle Injury Risk

    Did the risk of non-contact muscle injury differ between total genotype risk score categories? was this affected by maturation, and loading?

    8 Years

  • Tendon Injury Risk

    Did the risk of tendon injury differ between total genotype risk score categories? was this affected by maturation, and loading?

    8 Years

  • Ligament Injury Risk

    Did the risk of ligament injury differ between total genotype risk score categories? was this affected by maturation?

    8 Years

  • Apophysitis Injury Risk

    Did the risk of ligament injury differ between total genotype risk score categories? was this affected by maturation?

    8 Years

Study Arms (1)

Elite male youth footballers

Elite male youth footballers at an English championship / premier league football club

Genetic: Total Genotype Risk Score

Interventions

A total genotype risk score has been generated based on the results of previously observed genetic association studies

Elite male youth footballers

Eligibility Criteria

Age12 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Elite male football players aged 12-40

You may qualify if:

  • Elite male football players

You may not qualify if:

  • Female
  • non-elite

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fulham Football Club

London, New Malden, KT3 6PT, United Kingdom

Location

St Mary's University, Twickenham

London, Twickenham, TW1 4SX, United Kingdom

Location

MeSH Terms

Conditions

Sprains and StrainsTendon InjuriesGenetic Predisposition to Disease

Condition Hierarchy (Ancestors)

Wounds and InjuriesDisease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2022

First Posted

February 2, 2022

Study Start

December 1, 2019

Primary Completion

July 31, 2021

Study Completion

July 31, 2021

Last Updated

February 2, 2022

Record last verified: 2022-01

Locations